Titan Pharma’s Probuphine implant to treat OUD gains media attention in Canada

Television station, CFJC, of Kamloops, British Columbia, Canada has produced a segment about the first patient in the region to receive Titan Pharmaceuticals’ (NASDAQ:TTNP) Probuphine implant of buprenorphineas a new treatment in the battle against heroin and prescription painkiller addiction.

“This is going to be a game-changer in treating opioid use disorder,” Dr. Mandy Manak, who implanted one of her patients with Probuphine, told the TV station. “It’s also going to be a game-changer in how people live their lives in recovery.”